USE OF LACTOBACILLUS FERMENTUM U-21 STRAIN CELLS FOR PREVENTION OF PATHOLOGIC TISSUE CHANGE CAUSED BY OXIDATIVE STRESS

摘要

FIELD: pharmaceutics.;SUBSTANCE: invention relates to the pharmaceutical industry, namely to use of the Limosilactobacillus fermentum U-21 strain cell culture. Use of a cell culture of the Limosilactobacillus fermentum U-21 strain, filed by RNCIM under the number B-12075, in an effective amount for prevention and elimination of pathological changes caused by the oxidative stress in vital organs and tissues, namely in the liver, lungs, brain and nerve tissue.;EFFECT: described application allows reducing the level of tissue and organ cell damage, especially in nerve tissue.;4 cl, 2 dwg, 4 tbl, 4 ex